Back to results
CompletedPhase 2

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Rousse, Bulgaria

+34 additional locations

View on ClinicalTrials.gov